Davenport & Co’s Precigen PGEN Stock Holding History

Davenport & Co’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-25,700	Closed	-$168K	–	668
2018 Q4	$168K	Buy	25,700 +4,500	+21%	+$50.4K	﹤0.01%	602
2018 Q3	$365K	Sell	21,200 -19,500	-48%	-$290K	﹤0.01%	509
2018 Q2	$567K	Buy	+40,700	New	+$687K	0.01%	416

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Davenport & Co's PGEN Position: Q1 2019 in Review

Davenport & Co sold out of Precigen (PGEN) in Q1 2019, closing a stake of 25,700 shares — an estimated $168K sold.

Davenport & Co first reported a position in PGEN in Q2 2018 and held it in 3 quarters. The position peaked at $567K in Q2 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2019.

Davenport & Co reported no remaining Precigen position as of Q1 2019 after selling out during the quarter.
Davenport & Co sold 25,700 Precigen shares in Q1 2019, an estimated $168K.
Davenport & Co first reported a position in Precigen in Q2 2018 and held it in 3 quarters.
Davenport & Co's Precigen position peaked at $567K in Q2 2018.
166 funds tracked by Wall St. Rank held Precigen as of Q1 2019.

Based on Davenport & Co's 13F filing for Q1 2019, filed 17 Apr 2019.